Sheep with a green glow, indicating vaccination.

Brucellosis Breakthrough: Tagging Vaccines for Safer Sheep

Beau Callahan monogram
Beau Callahan in Health & Wellness October 2026 • 4 min read.

"Scientists are one step closer to eradicating brucellosis with a novel vaccine tagging method, ensuring healthier livestock and safer dairy for everyone."


Brucellosis is a global disease that hits both the economy and public health hard. It's a zoonosis, meaning it spreads from animals to humans, and it's a major concern wherever sheep and goats are raised. The disease leads to abortions in animals and reproductive issues, and that's just the start of the economic and health problems it brings.

For years, vaccination has been a key strategy in controlling brucellosis in sheep and goats. The B. melitensis Rev1 vaccine is widely used, but it comes with a significant drawback. It triggers a long-lasting antibody response, making it tough to distinguish vaccinated animals from those that are actually infected. This poses a challenge for disease surveillance and eradication programs.

Now, researchers are excited about a potential solution: a genetically modified version of the Rev1 vaccine tagged with green fluorescent protein (GFP). This innovative approach allows for easy identification of vaccinated animals, paving the way for more effective brucellosis control and eradication.

AI Search Multiple angles on this topic

Vaccination and Brucellosis Impact

A 2024 systematic review and meta-analysis recalculated the efficacy of Brucella vaccines in sheep and examined factors that may influence it, with the aim of informing vaccination protocols. A separate study reported that each 1% increase in vaccination coverage was associated with lower odds of herd-level brucellosis positivity (odds ratio 0.94, p = 0.02). At the animal level, the reported odds ratio was 0.96 (p = 0.06), a non-significant tendency; goats had higher vaccination coverage than sheep.

Vaccination Methods and Evidence Gaps

Vaccination is used to prevent brucellosis in sheep, and a 2024 systematic review and meta-analysis sought to develop rational recommendations for vaccination. A related source recommends intramuscular Rev.1, different inoculation protocols for sheep of different ages, and Rev.1 vaccination of pregnant ewes to prevent abortion. However, a 2022 narrative review says the advantages and limitations of Brucella vaccines, especially new candidates, have been less studied and calls for new control and eradication strategies.

How Does GFP Tagging Work?

Sheep with a green glow, indicating vaccination.

The researchers created a special strain of the Rev1 vaccine, called Rev1::gfp, by inserting a mini-Tn7-gfp into the glmS-recG region of the bacterial chromosome. This insertion ensures that the GFP is produced continuously, acting like a fluorescent tag on the vaccine strain. This doesn't mess with the normal operations of the vaccine, but it makes it super easy to spot.

To identify vaccinated animals, the team also developed an indirect ELISA-GFP test. This test detects antibodies against GFP in vaccinated animals. When sheep are vaccinated with the tagged vaccine, their immune systems produce antibodies against both Brucella and the GFP tag. If a blood sample tests positive for anti-GFP antibodies, it indicates that the animal has been vaccinated.

  • Visual Identification: The Rev1::gfp strain can be directly visualized under ultraviolet illumination or fluorescence microscopy.
  • PCR-GFP multiplex: A multiplex PCR test can identify the presence of the gfp gene in the vaccine strain.
  • ELISA-GFP test: This serological assay detects anti-GFP antibodies in vaccinated animals.
AI Search Multiple angles on this topic

Limits of Vaccine Identification

In a study of GFP-tagged Brucella melitensis Rev1, lambs given Rev1::gfp alone (n = 6) did not develop a significant anti-GFP response. Lambs given the vaccine together with recombinant GFP (n = 8) did develop such a response. A separate study reported that no vaccinated ewes had detectable IgG antibodies against CP28, while anti-CP28 reactivity was found in 80% (8 of 10) of experimentally infected ewes and 89% (25 of 28) of naturally infected ewes.

Efficacy Varies Across Vaccine Studies

A meta-analysis of sheep vaccination studies reported pooled vaccine efficacy of approximately 65% (RR = 0.35; 95% CI: 0.27–0.36). An earlier study of the Flu-BA vaccine reported efficacy of 57.1% in vaccinated non-pregnant sheep and 42.9% in goats, prompting evaluation of an improved formulation. Separately, a Rev1 study found that all tests performed equally when animals vaccinated as young were tested 125 days (four months) after vaccination. These findings describe different vaccines, outcomes, and study settings rather than a direct head-to-head comparison.

The Rev1::gfp strain maintained the same biological properties as the original Rev1 strain, including its effectiveness and safety. When tested in mice, it provided similar protection against Brucella infection. The real advantage is that the GFP tag allowed researchers to easily differentiate vaccinated animals from those infected with the bacteria. After vaccinating lambs, the scientists found that the Rev1::gfp vaccine didn't cause them to produce anti-GFP antibodies on their own. However, when they combined the vaccine with recombinant GFP, the lambs developed a strong and lasting anti-GFP antibody response. This response could be easily detected with the ELISA-GFP test.

Why This Matters

The ability to easily differentiate vaccinated from infected animals is a game-changer for brucellosis control programs. It enables more targeted surveillance, reduces unnecessary culling of livestock, and supports brucellosis eradication efforts. By tagging the Rev1 vaccine with GFP, scientists have created a valuable tool for improving livestock health and safeguarding public health.

AI Search Multiple angles on this topic

Economic and One Health Challenges

A 2023 systematic review of economic assessments describes livestock brucellosis as important to animal and human health authorities because of its socio-economic and public health consequences. It notes that benefit-cost analyses can help policymakers assess whether resources for control interventions are economically worthwhile. A One Health review emphasizes awareness and the correct use of diagnostic, epidemiological, and prophylactic tools. It also identifies inherited and emerging implementation challenges, some aggravated by global warming and intensified breeding to meet food demand.

Rev1's reported abortion rate against other vaccine types

  • 36.1%Across annotated studies, the reported abortion rate was 36.1% for Rev1, compared with 2.8% for RB51 and 0.3% for S19. The analysis did not find a statistically significant correlation between vaccine type and abortion rate.[1]Caveat: Vaccine type was not statistically significantly correlated with abortion rate.

What the vaccine comparisons do-and do not-show

The abortion-rate figures describe outcomes reported across annotated studies; the lack of a statistically significant correlation means these figures alone do not establish that vaccine type explains differences in abortion rates.[1]

How the Rev1 tagging approach fits the wider evidence

Another tagged Rev1 approach used wbdR and an ancillary ELISA as a possible way to address the distinction between vaccinated and infected animals. Its source says sheep experiments are necessary for a definite assessment, and reports that evaluation of serological response and protective capacity against B. ovis was in progress.[2]

The underlying identification problem is that Rev1 can prompt a lasting serological response, while vaccination-induced antibodies to smooth lipopolysaccharide are indistinguishable from those generated after field infection in conventional anti-LPS tests. GFP is described as an antigen from outside Brucella that can be paired with a diagnostic test; this is the rationale for a tag-based approach, not evidence that the tag itself establishes protection.[3]

What remains unresolved for tagged Rev1

  • Would the wbdR-tagged approach produce a measurable serological response and protective capacity against B. ovis in sheep, as the planned evaluation sought to assess?[2]
  • How well would a tagged vaccine’s identification strategy work in sheep while preserving the protection associated with the live vaccine? The cited sources describe the distinction problem and the need for sheep assessment, but do not resolve both questions for the GFP-tagged approach.[2] [3]

Sources

  1. Ontology-Based Meta-Analysis of Animal and Human Adverse Events Associated With Licensed Brucellosis Vaccines (pmc.ncbi.nlm.nih.gov)
  2. Rev1 wbdR tagged vaccines against Brucella ovis (pmc.ncbi.nlm.nih.gov)
  3. GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is brucellosis and why is it a concern?

Brucellosis is a zoonotic disease, meaning it can spread from animals to humans. It primarily affects sheep and goats, causing abortions and reproductive issues in animals. This leads to significant economic losses for farmers and poses a public health risk. The disease is a major concern in regions where these animals are raised, impacting both livestock health and the safety of dairy products. Vaccination is a key strategy to combat this.

2

What is the *B. melitensis Rev1* vaccine, and what are its limitations?

The *B. melitensis Rev1* vaccine is a widely used tool for controlling brucellosis in sheep and goats. However, a major drawback is that it triggers a long-lasting antibody response, making it difficult to differentiate vaccinated animals from those actually infected with brucellosis. This limitation complicates disease surveillance and eradication efforts.

3

How does GFP tagging of a vaccine work?

GFP tagging involves genetically modifying the *Rev1* vaccine to include a green fluorescent protein (GFP) marker. This modified vaccine, called *Rev1::gfp*, allows researchers to easily identify vaccinated animals because the GFP acts like a fluorescent tag. The presence of GFP can be detected using methods like fluorescence microscopy or specific antibody tests, enabling clear differentiation between vaccinated and infected animals.

4

What is the *ELISA-GFP* test, and how does it help in identifying vaccinated animals?

The *ELISA-GFP* test is designed to detect antibodies against GFP in vaccinated animals. When sheep are vaccinated with the *Rev1::gfp* vaccine, their immune systems produce antibodies against both Brucella and the GFP tag. A positive result for anti-GFP antibodies indicates that the animal has been vaccinated, providing a reliable way to distinguish vaccinated animals from those that may be infected.

5

Why is GFP tagging of the *Rev1* vaccine considered important for brucellosis control?

Tagging the *Rev1* vaccine with GFP is crucial for brucellosis control because it enables more effective surveillance and targeted interventions. By easily differentiating vaccinated from infected animals, resources can be focused on managing actual infections, reducing unnecessary culling of livestock, and improving the overall effectiveness of eradication programs. This approach enhances livestock health and safeguards public health by reducing the spread of brucellosis.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.